Pulmonary Fibrosis News
@pulmonaryfibros
We exist to bring you science, research and clinical news about PF. We are a free digital publication dedicated to the patient community.
08-04-2015 13:48:04
6,9K Tweets
2,4K Followers
260 Following
A Phase 2a trial is recruiting people with idiopathic pulmonary fibrosis to test GRI-0621, which targets natural killer T-cells. buff.ly/4ao2S23 #pulmonaryfibrosis #idiopathicpulmonaryfibrosis #PFcommunity #pulmonaryfibrosis awareness